European Journal of Cancer
Volume 39, Issue 9 , Pages 1271-1276, June 2003

Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases:

a phase II study of the EORTC Lung Cancer Group (08965)

  • R Dziadziuszko

      Affiliations

    • Department of Oncology and Radiotherapy, Medical University of Gdansk, 7 Debinki St., 80-211 Gdansk, Poland
    • Corresponding Author InformationCorresponding author. Tel./Fax: +48-58-349-2270
  • ,
  • A Ardizzoni

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
  • ,
  • P.E Postmus

      Affiliations

    • Vrije Universiteit Medical Center, Amsterdam, The Netherlands
  • ,
  • E.F Smit

      Affiliations

    • Vrije Universiteit Medical Center, Amsterdam, The Netherlands
  • ,
  • A Price

      Affiliations

    • University of Edinburgh, Edinburgh, UK
  • ,
  • C Debruyne

      Affiliations

    • European Organisation for Research and Treatment of Cancer Data Center, Brussels, Belgium
  • ,
  • C Legrand

      Affiliations

    • European Organisation for Research and Treatment of Cancer Data Center, Brussels, Belgium
  • ,
  • G Giaccone

      Affiliations

    • Vrije Universiteit Medical Center, Amsterdam, The Netherlands
  • ,
  • on behalf of the EORTC Lung Cancer Group

Received 31 January 2003; accepted 14 February 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(03)00234-X

doi:10.1016/S0959-8049(03)00234-X

European Journal of Cancer
Volume 39, Issue 9 , Pages 1271-1276, June 2003